Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive decline in lung function, worsening quality of life, and high mortality. However, the rate and pattern of progression of IPF ...
In a recent study published in Nature Metabolism, researchers investigated the association between cellular ... in mice with lung fibrosis and people with idiopathic pulmonary fibrosis (IPF).
The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...
The term “progressive pulmonary fibrosis” or “PPF” is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic ...
The aging and failure of cells that occurs when the liver is damaged can spread to other organs, suggests a new study in mice ...
The research focuses on 'cellular senescence,' a process where cells stop dividing and enter a state associated with chronic inflammation and aging. This cellular state, known as the senescence ...
The UAB ILD Center offers clinical trial enrollment for patients with idiopathic pulmonary fibrosis and other forms of diffuse parenchymal lung disease as part of a multidisciplinary and integrated ...
The research provides a stepping stone toward therapies that can control cellular aging, promoting longer, healthier lives.
New genetic tools reveal the dual roles of senescent cells in liver disease—macrophages drive fibrosis ... and manipulate ...
The UAB ILD Center offers clinical trial enrollment for patients with idiopathic pulmonary fibrosis and other forms of diffuse parenchymal lung disease as part of a multidisciplinary and integrated ...